Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...

Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the ...

Boston Scientific stock pulled back from its run at a record high on Wednesday despite reporting a sweeping third-quarter beat.

Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval ...

SGMC Health recently announced Kamil Hanna, MD, a cardiac electrophysiologist, has successfully performed the first Farapulse ...

Boston Scientific introduces next generation of cardiac mapping for the Farapulse PFA System: Marlborough, Massachusetts Monday, October 21, 2024, 11:00 Hrs [IST] Boston Scientifi ...

New FARAWAVETM NAV Ablation Catheter and FARAVIEWTM Software combine with OPAL HDxTM Mapping System to provide visualization ...